ARCHIVES

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

This article is from The Cancer Letter archive.

Vol. 14 No. 25 | June 17, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Diet Guideline Outlined At Senate Hearing

November 22, 1985

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012